AtHome Care Devices Market Poised for Growth Amid Pediatric Access Challenges BristolMyers Squibb BMY Draws Hedge Fund Attention with 425 Dividend Yield and AI Partnership Dow Jones Gains as Oil Drops Toward 90 Tesla Eyes Buy Point on Europe Sales Recovery Oil Marketing Stocks Rally as Brent Crude Dips Below 98 Fuel Prices Rise for Fourth Time Central Bank of India OFS Opens for Retail Investors Amid Cautious Analyst Outlook Rice Cultivation Emissions Surge Climate Impact Equivalent to 239 Million Cars Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares 7 BRX Q1 2026 Earnings Strong EPS Surprise of 635 Despite Slight Stock Decline ROP Q1 2026 Earnings EPS Surpasses Estimates by 258 Amid Market Headwinds ACRS Q1 2026 Earnings Narrower Net Loss Beats Expectations as Cost Management Continues Champion Homes Inc Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Vail Resorts MTN Q1 2026 Earnings EPS Misses Estimates Amid Seasonality Stock Edges Higher GH Research GHRS Jumps 335 as Shares Approach Key Resistance at 240 Healthcare Services Group Inc HCSG Rebounds as Support Holds Resistance Ahead Volato Group SOAR Edges Lower as Support Level Looms Key Levels in Focus Bluemount Holdings Limited BMHL Rises Modestly as Key Support Holds CeriBell CBLL Edges Lower Hovers Near Support Amid Modest Decline Federal Reserve Faces Diminishing Case for Rate Cuts as Jobs Data Signals Sticky Inflation Kewaunee Scientific Corporation KEQU Q1 2026 Earnings Reports 028 EPS Revenue Details Not Disclosed Cummins Inc CMI Surges 457 as Strong Momentum Builds Stellantis STLA Surges Nearly 4 as Bulls Defend 771 Support Level American Financial Group Subordinated Debentures AFGD Hold Steady Near 1986 Amid Low Volatility ABVC BioPharma Inc ABVC Holds Near Support Showing Cautious Recovery Potential Lazard Global Total Return and Income Fund LGI Sees Modest Uptick Amid RangeBound Trading Owlet Inc OWLT Holds Steady at 573 as Consolidation Narrows the Trading Range ASGI Holds Steady Near 2415 Amidst Modest Pullback Despite Strong Support Foundation Kura Oncology KURA Edges Higher Amid Broader Biotech Momentum